Explore Multiple Myeloma, Cancer and more!

Explore related topics

FDA Approves New Use for Daratumumab in Multiple Myeloma

December 2016 by NCI Staff Daratumumab attaches to a protein called which is present on the surface of cells, including in high numbers on myeloma cells.

Three-Drug Combination for Multiple Myeloma

February by NCI Staff Bortezomib blocks the action of the proteasome (pictured above), a cellular complex that eliminates and recycles proteins that are damaged or no longer needed.

En noviembre de 2015, la FDA aprobó tres nuevas terapias para pacientes con mieloma múltiple.

nice Three New Therapies Approved for Multiple Myeloma

CAR T-Cell Therapy for Multiple Myeloma - National Cancer Institute

June by NCI Staff Before (left) and after (right) PET scans of a patient with multiple myeloma treated with BCMA-targeted CAR T cells.

New Use for Lenalidomide in Multiple Myeloma

FDA aprueba un nuevo uso para la lenalidomida en mieloma múltiple

cancer risks

What Are the Risk Factors for Throat Cancer? As an otolaryngologist, Dr. James Freije has specialized training in treating cancerous conditions affecting the head and neck, including throat cancer.

Circulating Multiple Myeloma Tumor Cells

Blood biopsy offers new view of tumor evolution in multiple myeloma

Multiple Myeloma Cancer Awareness Shirt Walk Tee - Male Large - Black HomewiseShopperAwareness http://www.amazon.com/dp/B01AM5WIDE/ref=cm_sw_r_pi_dp_OS8Lwb1W7R9MN

Multiple Myeloma Cancer Awareness Shirt Walk Tee - Male Large - Black HomewiseShopperAwareness http://www.amazon.com/dp/B01AM5WIDE/ref=cm_sw_r_pi_dp_OS8Lwb1W7R9MN

Pinterest
Search